ADSK enters its May 28 earnings report with a notable divergence on the tape: options traders are the least defensive they've been in months, while a handful of Street analysts are quietly upgrading or reinstating coverage, even as the stock has shed nearly 6% on the week.
The most interesting development this week is the fresh analyst activity around ADSK. B of A Securities reinstated coverage yesterday with a Buy and a $300 target — a meaningful change from its prior Neutral stance. That follows Jefferies initiating at Buy in mid-April, also at $300. Neither firm is stretching on valuation. The mean analyst target now runs at roughly $325, implying close to 39% upside from the current $234.87 price. The factor score for analyst recommendation divergence ranks in the 94th percentile, meaning the consensus skew toward Buy is unusually strong relative to peers. Barclays trimmed its target this morning from $315 to $300 but kept its Overweight rating — a calibration, not a conviction change. Citigroup's April downgrade to Neutral (from Buy, target cut to $246 from $331) remains the most cautious note on the board.
Options positioning reinforces the improving sentiment picture. The put/call ratio has declined sharply over the past month. It now reads 1.38, well below its 20-day average of 1.51 and roughly 1.75 standard deviations below that mean — meaning the ratio of protective puts to calls is the lightest it has been in a while. For context, the ratio touched 1.66 in late April. The 52-week range runs from 0.85 to 1.80, so the current level is not extreme, but the direction of travel is clear: options traders have been unwinding hedges rather than adding them into the earnings date.
Short interest tells a quieter story. At 2.5% of free float, the short position is modest and has actually been declining over the past month — down nearly 6% from its end-March level, even as it ticked up about 4% on the week. Borrow conditions remain loose with availability well above any constraint level, and cost to borrow is negligible at around 0.37%. The ORTEX short score of 32 sits in the 61st percentile for its sector, suggesting shorts are present but not building an aggressive thesis here. This is not a stock where short-side pressure is the story.
The fundamental backdrop gives both bulls and bears material to work with ahead of the print. The bull case centres on accelerating revenue growth — up 14% last quarter with a 10% billings beat — and a management team entering FY27 with stated confidence in 9-10% underlying growth. The 12-month forward EPS growth estimate ranks in the 96th percentile universe-wide. The bear case focuses on execution risk in the billing model transition, macro sensitivity in construction and manufacturing end markets, and a valuation that, at roughly 18x earnings and 14x EV/EBITDA, leaves limited room for miss. The P/E has expanded about two points over the past 30 days even as the stock has pulled back this week, reflecting the earnings-driven re-rating from the February print.
Earnings history gives the setup added weight. The February 2026 print produced a +9.4% next-day move and a +17.5% five-day move. The November 2025 result delivered +4.0% next day and +7.0% over five days. Post-earnings rallies have been the pattern. Correlated peers have had a rough week — HUBS fell 27% over five days and GWRE dropped 6%, while ADSK's own 6% weekly decline tracks closer to the group average than to an outlier. What to watch heading into May 28 is whether the current options sentiment unwind holds, or whether put demand rebuilds as the event draws closer.
See the live data behind this article on ORTEX.
Open ADSK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
